CAS 1345847-93-9

Formel: C26H21F3N4O4

InChl: InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)

InChI Key: GNNDEPIMDAZHRQ-UHFFFAOYSA-N

SMILES: C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F

Altiratinib

CAS: 1345847-93-9

Altiratinib

Formel: C₂₆H₂₁F₃N₄O₄

Reinheit: ≥98%

Molekulargewicht: 510.46

Ref: 54-BUP06564

1,1-Cyclopropanedicarboxamide, n-[4-[[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-n'-(4-fluorophenyl)-

CAS: 1345847-93-9

Formel: C₂₆H₂₁F₃N₄O₄

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 510.4645

Ref: IN-DA009CGS

Altiratinib

CAS: 1345847-93-9

Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling,

Formel: C₂₆H₂₁F₃N₄O₄

Reinheit: 99.67% - 99.75%

Farbe und Form: Solid

Molekulargewicht: 510.4645

Ref: TM-T2054

Altiratinib

CAS: 1345847-93-9

N-[4-[[2-[(Cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-N′-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide

Formel: C₂₆H₂₁F₃N₄O₄

Reinheit: 99%

Molekulargewicht: 510.46

Ref: IN-DG329094

Altiratinib

CAS: 1345847-93-9

Inhibitor of MET, TIE2 and VEGFR2 kinases

Formel: C₂₆H₂₁F₃N₄O₄

Reinheit: Min. 95%

Molekulargewicht: 510.46 g/mol

Ref: 3D-FA137645

Altiratinib

CAS: 1345847-93-9

Formel: C₂₆H₂₁F₃N₄O₄

Molekulargewicht: 510.47

Ref: ST-EA-CP-A185000